Lupin Pharmaceuticals Inc. has voluntarily recalled 62,844 bottles of Cephalexin and Cefdinir oral suspension antibiotics due to the discovery of a dead ant inside the product. These prescription medications are used to treat bacterial infections in children and adults. The recall affects specific batches of these liquid medications distributed to wholesalers and distributors across the United States. Consumers should check their medicine cabinets for the specific lot numbers and bottle sizes listed to ensure their medication is safe to use.
The presence of a foreign substance, specifically a dead ant, in a liquid oral medication poses a risk of contamination and potential physical harm or allergic reaction if ingested. While the risk level is classified as low, foreign matter in pharmaceutical products indicates a potential breach in quality control during manufacturing.
Contact healthcare provider and return to pharmacy.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.